An IgM pan-T monoclonal antibody that blocks E-rosette formation

Area of Science:

• Immunology
• Cell Biology

Background:

• The T-cell E-rosette receptor is a key marker for T-lymphocytes.
• Monoclonal antibodies are crucial tools for cell characterization and manipulation.

Purpose of the Study:

• To develop and characterize a novel monoclonal antibody targeting the T-cell E-rosette receptor.
• To evaluate the antibody's specificity, binding characteristics, and cytotoxic potential.

Main Methods:

• Hybridoma technology was used to generate the antibody EDN-34B1 against a human T-cell leukemia line.
• Immunofluorescence, molecular weight analysis, and E-rosette blocking assays were performed.
• Cytotoxicity assays and functional assays (mitogen stimulation, mixed lymphocyte reaction) were conducted.

Main Results:

• EDN-34B1, an IgM antibody, exclusively targets T-cells and recognizes a 50,000 MW polypeptide.
• It effectively blocks E-rosette formation and is blocked by other anti-E-receptor antibodies.
• EDN-34B1 demonstrates 100% cytotoxicity against thymocytes and peripheral T-cells, exceeding the efficacy of Ab 9.6.

Conclusions:

• EDN-34B1 is a highly specific and potent antibody for T-cell targeting.
• Its cytotoxic properties enable efficient T-cell depletion from mixed populations.
• The IgM nature of EDN-34B1 may contribute to its enhanced T-cell killing efficiency.